Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABNB Airbnb	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jake Fuller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.62 -0.6%		Neutral
ACHC Acadia Healthcare	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.11 +2.4%	$25.00	Neutral
ACI Albertsons Companies	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.91 +0.6%	$27.00 ➝ $23.00	Overweight
ACNB ACNB	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$43.75 -0.5%		Outperform ➝ Market Perform
ACVA ACV Auctions	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Pierce Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.16 -5.5%	$16.00 ➝ $14.00	Buy
AEHR Aehr Test Systems	Target Set by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christian Schwab Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.15 -20.5%	$24.00	Buy ➝ Hold
AGL Agilon Health	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.08 -4.0%	$5.00 ➝ $1.50	Overweight
AIG American International Group	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Phillips Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.39 +0.4%	$85.00 ➝ $84.00	Equal Weight
AIG American International Group	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$83.39 +0.4%	$96.00 ➝ $99.00	Buy
AIZ Assurant	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$219.62 -0.9%	$230.00 ➝ $232.00	Equal Weight

ALLY Ally Financial	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.67 -0.3%	$45.00 ➝ $42.00	Overweight
ALM Almonty Industries	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Griffin Bryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.91 +3.3%	$7.00 ➝ $11.00	Buy
ALV Autoliv	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Juan Perez-Carrascosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.68 -3.7%	$123.00 ➝ $124.00	Buy ➝ Neutral
AMD Advanced Micro Devices	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.54 +4.3%	$168.00 ➝ $246.00	Equal Weight
AMD Advanced Micro Devices	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.54 +4.3%		Neutral
AMD Advanced Micro Devices	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.54 +4.3%	$185.00 ➝ $275.00	Overweight
AMD Advanced Micro Devices	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Lipacis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.54 +4.3%	$240.00	Outperform
AMD Advanced Micro Devices	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Stein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.54 +4.3%	$213.00 ➝ $273.00	Buy
AMD Advanced Micro Devices	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.54 +4.3%	$265.00	Buy
AMD Advanced Micro Devices	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.54 +4.3%	$200.00 ➝ $250.00	Buy
AML Aston Martin Lagonda Global	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 70.50 -3.6%	GBX 75 ➝ GBX 62	Neutral
AMRZ Amrize	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$47.15 -2.5%		Equal Weight
ANIX Anixa Biosciences	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.50 +7.8%	$10.00	Buy
AR Antero Resources	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.49 -1.2%	$43.00 ➝ $42.00	Equal Weight
ASTS AST SpaceMobile	Downgraded by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Coello Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.49 -3.3%		Sector Perform ➝ Sector Underperform
AVAV AeroVironment	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Moeller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$393.41 +0.4%	$305.00 ➝ $430.00	Buy
AVXL Anavex Life Sciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.19 +6.0%	$42.00	Buy
AXP American Express	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$327.53 -1.3%	$343.00 ➝ $355.00	Neutral
AZN AstraZeneca	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		£127.80 +0.4%	£145	Buy
BAC Bank of America	Target Raised by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$50.22 -0.3%	$57.00 ➝ $58.00	Outperform
BANC Banc of California	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Feaster Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.69 -0.7%		Outperform ➝ Strong-Buy
BANC Banc of California	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Feaster Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.69 -0.7%	$20.00	Outperform ➝ Strong-Buy
BGEO Lion Finance Group	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		7,710.00 +1.0%	GBX 9,200	Overweight
BHF Brighthouse Financial	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.74 -2.6%	$42.00 ➝ $46.00	Underweight
BLCO Bausch + Lomb	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.75 -0.9%		Neutral
BME B&M European Value Retail	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 236.37 -7.7%	GBX 400	Buy
BME B&M European Value Retail	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 236.37 -7.7%		Hold
BOW Bowhead Specialty	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.72 -2.0%	$34.00 ➝ $31.00	Equal Weight
BRLT Brilliant Earth Group	Initiated by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.16 +6.9%	$3.00	Buy
BRO Brown & Brown	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.99 +0.6%	$105.00 ➝ $100.00	Equal Weight

BSRT Baker Steel Resources	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 73.32 +2.9%		House Stock
BSX Boston Scientific	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$96.30 -0.4%	$110.00
BTSG BrightSpring Health Services	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.02 -2.9%	$27.00 ➝ $33.00	Overweight
BX Blackstone	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$164.99 -1.1%	$207.00 ➝ $199.00	Buy
BZAI Blaize	Initiated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.22 +3.4%	$8.50	Buy
CARE Carter Bankshares	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.52 +0.5%	$22.00	Outperform
CASS Cass Information Systems	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Yanchunis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.34 +0.5%	$47.00	Outperform
CBNA Chain Bridge Bancorp	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$32.17 +0.1%	$37.00	Strong-Buy
CBRE CBRE Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Kamdem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$152.36 -0.8%	$170.00 ➝ $180.00	Overweight
CFG Citizens Financial Group	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.28 -1.3%	$62.00	Strong-Buy
CGBD Carlyle Secured Lending	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Dodd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.17 -0.8%	$15.00	Market Perform ➝ Outperform
CI Cigna Group	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$308.28 +1.7%	$340.00 ➝ $354.00	Equal Weight
CMA Comerica	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.14 -0.1%	$83.00	Underweight ➝ Equal Weight
CMA Comerica	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Chiaverini Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.14 -0.1%	$75.00 ➝ $85.00	Hold
CMCSA Comcast	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Swinburne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.11 +0.0%	$38.00 ➝ $35.00	Equal Weight
CNC Centene	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.65 +2.7%	$30.00 ➝ $41.00	Equal Weight
CNP CenterPoint Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.61 +0.4%	$39.00 ➝ $40.00	Equal Weight
CNX CNX Resources	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.15 -0.5%	$33.00 ➝ $32.00	Equal Weight
COF Capital One Financial	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.72 -0.5%	$248.00 ➝ $235.00	Neutral
COP ConocoPhillips	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$93.97 -1.0%	$122.00 ➝ $118.00	Overweight
CRBG Corebridge Financial	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.37 +0.5%	$40.00 ➝ $39.00	Overweight
CSWC Capital Southwest	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Dodd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.88 -3.5%		Outperform ➝ Market Perform
CTRA Coterra Energy	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.93 +0.4%	$37.00 ➝ $35.00	Overweight
CTRA Coterra Energy	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.93 +0.4%	$33.00 ➝ $35.00	Overweight
CVS CVS Health	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.15 +0.4%	$84.00 ➝ $103.00	Overweight
CVSG CVS Group	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,370 +9.6%	GBX 1,600	Buy
CVX Chevron	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$153.40 -0.4%	$160.00 ➝ $158.00	Equal Weight
CWK Cranswick	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 4,871.77 -0.7%		House Stock
CYH Community Health Systems	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.19 +3.1%	$2.50 ➝ $3.00	Underweight
D Dominion Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.64 +0.2%	$60.00 ➝ $63.00	Overweight
D Dominion Energy	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Amicucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.64 +0.2%	$67.00	In-Line
DHI D.R. Horton	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.39 -5.3%	$185.00 ➝ $169.00	Outperform ➝ In-Line
DKNG DraftKings	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$32.92 -5.9%	$58.00 ➝ $54.00	Outperform
DLTR Dollar Tree	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Corey Tarlowe Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.78 -2.2%	$110.00 ➝ $70.00	Hold ➝ Underperform
DOCN DigitalOcean	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Hickey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.07 -0.8%	$32.00 ➝ $40.00	Neutral
DVN Devon Energy	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.25 -1.9%	$42.00 ➝ $40.00	Equal Weight
EAT Brinker International	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Ivankoe Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.43 +0.7%	$175.00	Neutral ➝ Overweight
EBAY eBay	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.24 -0.6%	$84.00 ➝ $89.00	Equal Weight
ECG Everus Construction Group	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ian Zaffino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.02 -1.0%	$90.00	Outperform
ED Consolidated Edison	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Amicucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.04 +0.7%	$106.00	In-Line
EG Everest Group	Reiterated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$364.52 +0.8%		Hold
ELAN Elanco Animal Health	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Schott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.68 +0.1%	$18.00 ➝ $24.00	Neutral ➝ Overweight
ELV Elevance Health	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$355.43 +1.6%	$330.00 ➝ $412.00	Overweight
EME EMCOR Group	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$666.85 -0.5%	$676.00	Sell ➝ Neutral
ENLAY Enel	Downgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.48 -0.8%		Buy ➝ Hold
EOG EOG Resources	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Hanold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.31 -1.0%	$140.00 ➝ $145.00	Outperform
EOG EOG Resources	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.31 -1.0%	$140.00 ➝ $136.00	Equal Weight
EQH Equitable	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.76 -0.3%	$67.00 ➝ $61.00	Overweight
EQT EQT	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.78 -0.7%	$68.00 ➝ $67.00	Overweight
EQT EQT	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Hanold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.78 -0.7%	$60.00 ➝ $62.00	Sector Perform

ESNT Essent Group	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.27 -0.1%	$66.00 ➝ $65.00	Overweight ➝ Neutral
ESTA Establishment Labs	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.85 +1.3%		Neutral
ETSY Etsy	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.58 +0.8%	$57.00 ➝ $58.00	Underweight
EW Edwards Lifesciences	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.30 +1.0%	$80.00 ➝ $88.00	In-Line ➝ Outperform
EXAS Exact Sciences	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.75 +0.2%	$68.00	Outperform
EXE Expand Energy	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.17 -0.5%	$139.00 ➝ $136.00	Overweight
FANG Diamondback Energy	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$146.28 -1.9%	$185.00 ➝ $178.00	Overweight
FCNCA First Citizens BancShares	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,766.91 +0.4%	$2,100.00
FCNCA First Citizens BancShares	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,766.91 +0.4%		Outperform
FFBC First Financial Bancorp.	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.93 -0.3%	$30.00	Market Perform ➝ Outperform
FHI Federated Hermes	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kenneth Worthington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.90 +1.8%	$54.00 ➝ $55.00	Neutral
FHN First Horizon	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.04 -0.1%	$25.00	Outperform
FITB Fifth Third Bancorp	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$43.69 -0.2%	$53.00 ➝ $57.00	Buy
FITB Fifth Third Bancorp	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.69 -0.2%	$56.00 ➝ $60.00	Equal Weight ➝ Overweight
FITB Fifth Third Bancorp	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$43.69 -0.2%	$50.00 ➝ $48.00	Overweight
FITB Fifth Third Bancorp	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$43.69 -0.2%	$47.00 ➝ $50.00	Market Perform
FLNC Fluence Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christine Cho Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.18 -7.1%	$8.00 ➝ $14.00	Equal Weight
FOXF Fox Factory	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter McGoldrick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.52 -2.5%	$33.00
FRT Federal Realty Investment Trust	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.96 -0.8%	$105.00	Inline
FRT Federal Realty Investment Trust	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$97.96 -0.8%	$105.00	Buy ➝ Hold
FTRE Fortrea	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.40 -1.9%		Neutral
FULT Fulton Financial	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.67 -0.1%	$21.00	Market Perform ➝ Outperform
GBCI Glacier Bancorp	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Feaster Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.95 -0.4%	$55.00	Outperform
GEHC GE HealthCare Technologies	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.96 -1.9%	$93.00 ➝ $83.00	Buy ➝ Neutral
GEMI Gemini Space Station	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Knoblauch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.80 -1.9%	$37.00	Overweight
GEMI Gemini Space Station	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.80 -1.9%	$41.00	Equal Weight
GEMI Gemini Space Station	Initiated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.80 -1.9%	$27.00	Market Perform
GEMI Gemini Space Station	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Frisch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.80 -1.9%	$30.00	Outperform
GEMI Gemini Space Station	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.80 -1.9%	$31.00	Buy
GEMI Gemini Space Station	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Christiansen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.80 -1.9%	$26.00	Neutral
GEMI Gemini Space Station	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.80 -1.9%	$25.00	Neutral
GEMI Gemini Space Station	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Cyprys Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.80 -1.9%	$29.00	Equal Weight
GEMI Gemini Space Station	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Todaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.80 -1.9%	$42.00	Buy
GEMI Gemini Space Station	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Brendler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.80 -1.9%	$30.00	Buy
GEMI Gemini Space Station	Initiated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.80 -1.9%	$30.00	Outperform
GOOGL Alphabet	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.20 -1.7%	$187.00 ➝ $236.00	Equal Weight
GOOGL Alphabet	Initiated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Rossington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.20 -1.7%	$285.00	Buy
GPE Great Portland Estates	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 325 -0.6%	GBX 375	Buy
GTLB GitLab	Downgraded by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.10 -6.4%	$52.00	Outperform ➝ Neutral
HBT HBT Financial	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Tamayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.05 +0.3%		Outperform ➝ Market Perform
HCA HCA Healthcare	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$439.01 +1.3%	$444.00	Overweight
HCA HCA Healthcare	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$439.01 +1.3%	$375.00 ➝ $412.00	Equal Weight
HCAT Health Catalyst	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.86 -3.3%	$4.00	Neutral
HG Hamilton Insurance Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.83 -0.5%	$23.00 ➝ $25.00	Equal Weight
HIG The Hartford Insurance Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$133.63 +0.8%	$135.00 ➝ $140.00	Equal Weight
HOC Hochschild Mining	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 381.74 -0.7%	GBX 340	Buy
HOLX Hologic	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.67 +0.5%	$69.00 ➝ $78.00	In-Line ➝ Outperform
HUM Humana	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$292.76 -0.8%	$344.00 ➝ $347.00	Overweight
IART Integra LifeSciences	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.46 -0.3%		Sell
IBP Installed Building Products	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$234.90 -1.9%	$240.00

ICCM IceCure Medical	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.98 -1.7%	$2.00 ➝ $2.50	Buy
IEX IDEX	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Blair Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.37 -1.6%	$210.00
IFF International Flavors & Fragrances	Target Lowered by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexandra Yates Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.44 -0.1%	$85.00 ➝ $70.00	Buy
IP International Paper	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabe Hajde Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.80 -0.2%	$43.00 ➝ $44.00	Underweight
IPG Interpublic Group of Companies	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Roch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.27 +1.7%	$27.50 ➝ $28.00	Equal Weight
IPWR Ideal Power	Reiterated by	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.21 -4.1%		Hold
ITRI Itron	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tommy Moll Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.85 +0.7%	$130.00	Equal Weight
JNJ Johnson & Johnson	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$188.40 +0.1%		Buy
JXN Jackson Financial	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.42 -1.2%	$97.00 ➝ $106.00	Equal Weight
KAPA Kairos Pharma	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.25 +2.0%	$9.00	Buy
KBH KB Home	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.42 -4.7%	$73.00 ➝ $65.00	Outperform ➝ In-Line
KMX CarMax	Downgraded by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Lick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.41 -3.0%	$42.00	Overweight ➝ Equal Weight
KMX CarMax	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Albanese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.41 -3.0%	$75.00 ➝ $60.00	Buy
KNSL Kinsale Capital Group	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$472.26 -0.5%	$525.00 ➝ $500.00	Overweight
LEGN Legend Biotech	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Schmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.23 -0.7%	$40.00	Overweight
LEN Lennar	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.86 -2.8%	$114.00
LIO Liontrust Asset Management	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 314.22 -4.2%	GBX 435	Buy
LMND Lemonade	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.84 -4.0%	$43.00 ➝ $45.00	Underweight
LMP LondonMetric Property	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 183.01 +0.4%	GBX 240	Buy
LMP LondonMetric Property	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 183.01 +0.4%		Buy
LNC Lincoln National	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.19 -0.1%	$58.00 ➝ $53.00	Overweight
LSEG London Stock Exchange Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 8,570 -0.1%	£135	Buy
LXEO Lexeo Therapeutics	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mani Foroohar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.24 +27.3%	$9.00 ➝ $20.00	Outperform
MDT Medtronic	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$98.51 +0.1%		Buy
MET MetLife	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.71 +0.4%	$94.00 ➝ $97.00	Overweight
META Meta Platforms	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$708.96 -0.9%	$811.00 ➝ $837.00	Overweight
MFIC MidCap Financial Investment	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.77 +0.5%	$13.50	Market Perform ➝ Outperform
MKL Markel Group	Reiterated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,965.95 +0.4%		Hold
MKS Marks and Spencer Group	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 378.84 +1.0%		Overweight
MLTX MoonLake Immunotherapeutics	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.87 +2.4%	$25.00
MMC Marsh & McLennan Companies	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Phillips Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.16 +0.9%	$220.00 ➝ $215.00	Equal Weight
MMSI Merit Medical Systems	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.15 -0.2%	$103.00	Outperform
MNDI Mondi	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 837.20 -4.8%	GBX 1,530 ➝ GBX 1,250	Buy
MOH Molina Healthcare	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$203.97 +1.7%	$198.00 ➝ $231.00	Overweight
MSDL Morgan Stanley Direct Lending Fund	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.45 -0.8%	$18.50	Market Perform ➝ Outperform
MSGS Madison Square Garden	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tony DiMatteo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$219.79 -5.2%		Neutral
MTH Meritage Homes	Downgraded by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.76 -3.4%	$100.00 ➝ $82.00	Outperform ➝ In-Line
MU Micron Technology	Initiated by	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$185.09 -3.1%	$249.00	Outperform
MVBF Mvb Financial	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.05 +1.7%	$30.00	Outperform
NAK Northern Dynasty Minerals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.81 +19.9%	$2.50	Buy
NAVI Navient	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.51 -2.8%	$15.00 ➝ $14.00	Neutral
NEXN Nexxen International	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler DiMatteo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.58 +2.6%	$13.00	Buy
NFLX Netflix	Initiated by	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,189.38 +2.2%	$1,514.00	Outperform
NFLX Netflix	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Blackledge Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,189.38 +2.2%	$1,450.00 ➝ $1,425.00	Buy
NFLX Netflix	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,189.38 +2.2%	$1,425.00
NFLX Netflix	Reiterated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,189.38 +2.2%		Buy
NMIH NMI	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.24 -0.4%	$44.00 ➝ $43.00	Overweight
OBDC Blue Owl Capital	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.50 -0.4%	$14.00	Market Perform ➝ Outperform
OC Owens Corning	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Philip Ng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$133.12 -2.7%	$185.00 ➝ $180.00	Buy
OC Owens Corning	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$133.12 -2.7%	$153.00

OCS Oculis	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.86 +1.6%	$33.00 ➝ $36.00	Buy
OLN Olin	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Sison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.71 -4.7%	$21.00 ➝ $25.00	Equal Weight
OMF OneMain	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.65 -1.5%	$63.00 ➝ $57.00	Overweight ➝ Neutral
OPRT Oportun Financial	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.41 -5.8%	$8.00 ➝ $6.00	Neutral ➝ Underweight
ORA Ormat Technologies	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.58 +0.4%	$97.00 ➝ $120.00	Buy
OSCR Oscar Health	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.23 +4.1%	$10.00 ➝ $14.00	Underweight
OSW OneSpaWorld	Target Set by	Northcoast Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.11 +1.1%	$28.00	Buy
OVV Ovintiv	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.28 -2.0%	$57.00 ➝ $55.00	Overweight
OXB Oxford Biomedica	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 629.53 -1.2%	GBX 451	Buy
PAA Plains All American Pipeline	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.53 -1.1%	$18.00 ➝ $17.00	Underweight
PAGP Plains GP	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.68 -1.4%	$18.00 ➝ $17.00	Underweight
PB Prosperity Bancshares	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$65.97 -0.2%	$75.00
PEG Public Service Enterprise Group	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Amicucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.51 -0.4%	$83.00	In-Line
PFG Principal Financial Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.53 -0.8%	$77.00 ➝ $80.00	Underweight
PFSI PennyMac Financial Services	Downgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Bose Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$115.69 -2.2%	$129.00	Outperform ➝ Market Perform
PHM PulteGroup	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.60 -4.3%	$163.00 ➝ $154.00	Outperform ➝ In-Line
PKG Packaging Corporation of America	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabe Hajde Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$210.50 -1.1%	$200.00 ➝ $222.00	Equal Weight
PNW Pinnacle West Capital	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.91 +1.2%	$93.00 ➝ $95.00	Equal Weight
PRI Primerica	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$274.72 -1.0%	$308.00 ➝ $306.00	Equal Weight
PRTA Prothena	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew S. Fein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.11 +2.5%	$14.00 ➝ $20.00	Buy
PRU Prudential Financial	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.50 +0.3%	$117.00 ➝ $118.00	Equal Weight
PSX Phillips 66	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.40 -1.1%	$127.00 ➝ $132.00	Equal Weight
QDEL QuidelOrtho	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Donnelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.16 -4.9%	$40.00 ➝ $33.00	Buy ➝ Neutral
RCUS Arcus Biosciences	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asthika Goonewardene Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.10 -2.7%	$32.00 ➝ $39.00	Buy
RDDT Reddit	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.47 +0.4%	$155.00 ➝ $174.00	Cautious
RGNX REGENXBIO	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.37 -3.0%	$34.00	Buy
RGTI Rigetti Computing	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.92 +2.9%	$20.00 ➝ $50.00	Buy
RJF Raymond James Financial	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Worthington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$165.86 -1.1%	$172.00 ➝ $178.00	Neutral
RNR RenaissanceRe	Reiterated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$267.89 +0.6%		Hold
RTO Rentokil Initial	Upgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Kirkness Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.56 +3.7%		Underperform ➝ Outperform
RYAN Ryan Specialty	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.88 +0.1%	$68.00 ➝ $65.00	Overweight
SAA M&C Saatchi	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 143 +1.8%	GBX 185	Buy
SBCF Seacoast Banking Corporation of Florida	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.69 +0.7%	$33.00	Outperform
SDRL Seadrill	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.56 -1.9%	$33.00	Equal Weight
SFBS ServisFirst Bancshares	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$82.24 -0.1%	$95.00	Market Perform ➝ Outperform
SGRY Surgery Partners	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.39 0.0%	$36.00	Overweight
SHC Sotera Health	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.16 -0.4%		Neutral
SIGI Selective Insurance Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.54 -0.8%	$72.00 ➝ $73.00	Underweight
SLM SLM	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.55 -2.1%	$38.00 ➝ $29.00	Overweight ➝ Neutral
SLNO Soleno Therapeutics	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$62.19 +6.4%	$125.00	Buy
SNAP Snap	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.21 -3.7%	$7.00 ➝ $8.00	Equal Weight
SNWV Sanuwave Health	Target Set by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Bauser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.73 -24.7%	$53.00	Buy
STZ Constellation Brands	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.92 +1.6%	$160.00
STZ Constellation Brands	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.92 +1.6%	$176.00 ➝ $160.00	Equal Weight
SW Smurfit Westrock	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabe Hajde Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.84 +1.3%	$46.00 ➝ $52.00	Equal Weight ➝ Overweight
SYF Synchrony Financial	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Shane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.21 -1.6%	$80.00 ➝ $75.00	Overweight ➝ Neutral
SYK Stryker	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$368.41 +0.6%	$410.00
TBLA Taboola.com	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.21 -2.3%		Neutral
TCEHY Tencent	Initiated by	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$86.26 -1.2%		Outperform
TEP Telecom Plus	Reiterated by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,847.33 +1.4%	GBX 2,600	Buy
TFC Truist Financial	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.33 +0.0%		Outperform
THC Tenet Healthcare	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.39 +2.3%	$190.00	Overweight
THC Tenet Healthcare	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.39 +2.3%	$200.00 ➝ $238.00	Overweight
THG The Hanover Insurance Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$184.53 0.0%	$185.00 ➝ $190.00	Equal Weight
TMQ Trilogy Metals	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.93 +231.4%		Market Perform ➝ Outperform
TMQ Trilogy Metals	Reiterated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.93 +231.4%		Hold
TNDM Tandem Diabetes Care	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.01		Neutral
TOL Toll Brothers	Reiterated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$133.93 -4.8%	$169.00 ➝ $160.00	Outperform ➝ In-Line
TPH Tri Pointe Homes	Reiterated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.62 -3.7%	$38.00 ➝ $34.00	Outperform ➝ In-Line
TRGP Targa Resources	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeremy Tonet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$163.68 +0.7%	$214.00 ➝ $215.00	Overweight
TRUE TrueCar	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Pierce Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.56 -14.6%		Buy ➝ Hold
TRV Travelers Companies	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Phillips Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$286.04 +1.2%	$269.00 ➝ $285.00	Equal Weight
TSM Taiwan Semiconductor Manufacturing	Initiated by	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$295.32 -2.3%		Outperform
TTWO Take-Two Interactive Software	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alec Brondolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$259.97 +1.2%	$270.00 ➝ $277.00	Overweight
TWFG TWFG	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.36 -0.2%	$32.00 ➝ $30.00	Equal Weight
TXRH Texas Roadhouse	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Ivankoe Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$166.83 -0.2%	$200.00 ➝ $182.00	Neutral
U Unity Software	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alec Brondolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.12 -3.8%	$29.00 ➝ $37.00	Equal Weight
UHS Universal Health Services	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$210.18 +1.6%	$210.00 ➝ $249.00	Overweight
UHS Universal Health Services	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$210.18 +1.6%	$227.00	Neutral
UNH UnitedHealth Group	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$361.05 +0.6%	$267.00 ➝ $400.00	Overweight
UNM Unum Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.41 -0.3%	$79.00 ➝ $81.00	Equal Weight
VECO Veeco Instruments	Downgraded by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$30.00 -2.8%	$30.00	Outperform ➝ Market Perform
VEEV Veeva Systems	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Rhyee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$304.88 +1.7%	$297.00 ➝ $380.00	Hold ➝ Buy
VFC V.F.	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.25 -1.8%	$15.00	Neutral
VIA Via Transportation	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ho Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.44 -3.2%		Outperform
VIA Via Transportation	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Zukin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.44 -3.2%	$60.00	Outperform
VIA Via Transportation	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.44 -3.2%	$59.00	Outperform
VIA Via Transportation	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.44 -3.2%	$55.00	Buy
VIA Via Transportation	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.44 -3.2%	$50.00	Neutral
VIA Via Transportation	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.44 -3.2%	$55.00	Buy
VIA Via Transportation	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.44 -3.2%	$59.00	Mkt Outperform
VIA Via Transportation	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.44 -3.2%		Outperform
VIA Via Transportation	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.44 -3.2%	$60.00	Overweight
VIA Via Transportation	Initiated by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.44 -3.2%	$59.00	Market Outperform
VIA Via Transportation	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Baer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.44 -3.2%	$53.00	Equal Weight
VIA Via Transportation	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.44 -3.2%	$55.00	Outperform
VIA Via Transportation	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.44 -3.2%	$58.00	Buy
VNOM Viper Energy	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.67 -3.2%	$57.00
VOYA Voya Financial	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$75.15 -0.4%	$90.00 ➝ $91.00	Overweight
W7L Warpaint London	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 212 -3.6%	GBX 700 ➝ GBX 440	Outperform
WST West Pharmaceutical Services	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Markowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$265.47 -1.0%	$350.00
WYY WidePoint	Reiterated by	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.35 +0.7%	$9.00	Buy
XENE Xenon Pharmaceuticals	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rudy Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.12 -1.1%	$55.00	Buy
XENE Xenon Pharmaceuticals	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.12 -1.1%		Outperform
XOM Exxon Mobil	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.46 -0.6%	$127.00 ➝ $126.00	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:30 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings